Galectin-3 and Myeloperoxidase May Monitor Cancer-Therapy-Related Cardiotoxicity? A Systematic Review and Meta-Analysis

Galectin-3 and myeloperoxidase (MPO) are novel biomarkers in the field of cardio-oncology, but conflicting results have been reported. Hence, a meta-analysis was performed to assess the monitoring value of galectin-3 and MPO in cancer-therapy-related cardiotoxicity. PubMed, Cochrane, Web of Science,...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Yujuan, Gao, Diansa, Xue, Jinmin, Zuo, Zhong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Systematic Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9775944/
https://www.ncbi.nlm.nih.gov/pubmed/36551214
http://dx.doi.org/10.3390/biom12121788

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9775944/
https://www.ncbi.nlm.nih.gov/pubmed/36551214
http://dx.doi.org/10.3390/biom12121788

Ejemplares similares